What is he best known for?
The fields of study he is best known for:
Aart G. Jochemsen focuses on MDMX, Cancer research, Mdm2, Cell biology and Proto-Oncogene Proteins c-mdm2.
His Cancer research research integrates issues from Carcinogenesis, Tumor suppressor gene, Mutation, Downregulation and upregulation and Retinoblastoma.
Aart G. Jochemsen has included themes like Regulator, Ubiquitin ligase, Transfection and Nuclear export signal in his Mdm2 study.
His Cell biology research incorporates elements of Nuclear protein, Transcription, Transactivation and Mutant.
Aart G. Jochemsen interconnects Molecular biology and Ubiquitin in the investigation of issues within Nuclear protein.
His work in Proto-Oncogene Proteins c-mdm2 addresses subjects such as Ring finger, which are connected to disciplines such as Zinc finger.
His most cited work include:
- MDMX: a novel p53-binding protein with some functional properties of MDM2. (500 citations)
- Inactivation of the p53 pathway in retinoblastoma (462 citations)
- Rescue of embryonic lethality in Mdm4 -null mice by loss of Trp53 suggests a nonoverlapping pathway with MDM2 to regulate p53 (420 citations)
What are the main themes of his work throughout his whole career to date?
His main research concerns Cancer research, Cell biology, Molecular biology, MDMX and Mdm2.
His Cancer research research includes elements of Tumor suppressor gene, Apoptosis, Cell cycle and Cell culture.
The concepts of his Cell biology study are interwoven with issues in Ubiquitin, Mutant, DNA damage and Biochemistry.
His Molecular biology study combines topics from a wide range of disciplines, such as Gene expression, Transfection, Gene, Transcription and Gene isoform.
In his research on the topic of MDMX, Ring finger is strongly related with Proto-Oncogene Proteins c-mdm2.
His Mdm2 study combines topics in areas such as Retinoblastoma, Regulator and Ubiquitin ligase.
He most often published in these fields:
- Cancer research (49.61%)
- Cell biology (31.01%)
- Molecular biology (26.36%)
What were the highlights of his more recent work (between 2016-2021)?
- Cancer research (49.61%)
- Melanoma (17.05%)
- Cell growth (10.85%)
In recent papers he was focusing on the following fields of study:
Aart G. Jochemsen spends much of his time researching Cancer research, Melanoma, Cell growth, Cell culture and Gene.
His Cancer research research is multidisciplinary, incorporating perspectives in Gene knockdown, Phenotype, Inflammation, Mdm2 and Metastasis.
His research on Mdm2 also deals with topics like
- Kinase which intersects with area such as PI3K/AKT/mTOR pathway and Cell cycle,
- Gene isoform that connect with fields like In vivo.
His studies in Melanoma integrate themes in fields like Apoptosis and Malignancy.
His studies deal with areas such as Origin of replication, DNA Replication Fork, DNA, Protein kinase C and MDMX as well as Cell growth.
His work investigates the relationship between Growth inhibition and topics such as Carcinogenesis that intersect with problems in Cell biology.
Between 2016 and 2021, his most popular works were:
- Targeting of the MAPK and AKT pathways in conjunctival melanoma shows potential synergy (32 citations)
- Combined inhibition of CDK and HDAC as a promising therapeutic strategy for both cutaneous and uveal metastatic melanoma (21 citations)
- MDM4 is a rational target for treating breast cancers with mutant p53 (20 citations)
In his most recent research, the most cited papers focused on:
His main research concerns Melanoma, Cancer research, Cutaneous melanoma, Conjunctival Melanoma and Clinical trial.
His study in Melanoma is interdisciplinary in nature, drawing from both Phenotype, Inflammation, RELB, Downregulation and upregulation and Human leukocyte antigen.
His work carried out in the field of Cancer research brings together such families of science as NFKB1, Mutant, Immune system, Growth inhibition and Cell cycle.
His research integrates issues of Position paper, Internal medicine, Disease, Etiology and Mucosal melanoma in his study of Cutaneous melanoma.
His research in Conjunctival Melanoma intersects with topics in Protein kinase B, MEK inhibitor and Pathology.
The study incorporates disciplines such as Viability assay, Apoptosis, Cyclin-dependent kinase and Adverse effect in addition to Clinical trial.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
